Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has been ...

Vertex Pharma's non-opioid painkiller suzetrigine was unable to perform better than placebo in a phase 2 trial in lumbosacral radiculopathy (LSR), a form of neuropathic back pain, ahead of an FDA ...

News headlines Vertex Pharmaceuticals is facing challenges in its pain management program, prompting a major fund to exit its position. Despite recent analyst upgrades, the stock trades significantly ...

View the basic VRTX option chain and compare options of Vertex Pharmaceuticals Incorporated on Yahoo Finance.

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Discover the top tutorials for learning foreshortening and perspective, two essential skills for drawing depth and realism. This video highlights the best learning resources, explains why these ...